CVRx President and CEO Nadim Yared Named Chairman of the Medical Device Innovation Consortium (MDIC) Board of Directors

ARLINGTON, Va.–(BUSINESS WIRE)–#CVRx–The Medical
Device Innovation Consortium (MDIC)
, announced that CVRx’s President
and CEO Nadim Yared has been named chairman of the MDIC Board of
Directors and Executive Committee for a two-year term. Yared has served
on the MDIC Board of Directors since 2013. He will succeed Abiomed
President and CEO, Michael Minogue who will remain on the Board.

“Since its inception, MDIC has worked to transform regulatory processes
to deliver critical, innovative medical technologies in a timely manner
to U.S. patients who need them,” said Yared. “I am excited to take on
this role as Chairman of the Board for MDIC, and to work alongside
fellow board members, MDIC leadership, and its membership as we deepen
the organization’s commitment to bring together government, industry,
and non-profit partners to support timely, safe, and cost-effective
medical device innovation.”

Yared is currently President and CEO of CVRx, a private company that has
developed an implantable medical device to treat high blood pressure. He
previously served as Vice President and General Manager of Medtronic
Navigation, the leading supplier of integrated image-guided surgery
products in the world. He joined Medtronic Navigation in 2002 after a
10-year career with GE Medical, where he held engineering and marketing
management positions of increasing responsibility, including Vice
President and General Manager of GE’s European X-ray business. Yared
received an engineering degree from Ecole Nationale Supérieure des
Télécommunications and an MBA from INSEAD in France. Yared was
recognized as one of the “100 people to know in 2017” Minneapolis’ Twin
Cities Business Magazine.

“Nadim has extensive experience in the medtech industry and has made
significant contributions as a member of MDIC’s Board of Directors over
the past six years,” said Pamela Goldberg, president and CEO of MDIC. “I
look forward to working even more closely with Nadim as we continue to
accelerate patient access to innovative medical technologies.”

About the Medical Device Innovation Consortium

Founded in 2012, the Medical Device Innovation Consortium (MDIC) is the
first public-private partnership created with the sole objective of
advancing medical device regulatory science throughout the total product
life cycle. MDIC’s mission is to promote public health through science
and technology and to enhance trust and confidence among stakeholders.
MDIC works in the pre-competitive space to facilitate the development of
methods, tools, and approaches that enhance understanding and improve
evaluation of product safety, quality, and effectiveness. Its
initiatives aim to improve product safety and patient access to
cutting-edge medical technology while reducing cost and time to market.
For more information, visit http://www.mdic.org.

Contacts

Leah McConnell
lmcconnell@mdic.org
+
1 202-900-9099

Staff

Recent Posts

Olympian Gabby Thomas Draws Crowd at Wellness Event with BetterWay(TM) Blood Testing at H-E-B SoCo

Guests had an opportunity to meet Gabby Thomas, win health-focused prizes, and learn simple ways…

9 hours ago

UOG (United One Group) Wins Three Prestigious Industry Awards at CES 2026

CES Official Spokesperson Highlights UOG Featured ProductsIntroducing the World's First Black Diamond Carbon & Nano…

18 hours ago

Best Ipamorelin vs Sermorelin: Growth Hormone Peptide Comparison 2026 — ReadyRx Prescription Telehealth Analysis

Independent research summary reviews mechanisms, regulatory considerations, and telehealth access pathways as consumers compare growth…

20 hours ago

GLP-1 Booster From Health Journey: 2026 Ingredient Analysis And Probiotic Metabolic Support Explained

Examining Akkermansia Muciniphila, Clostridium Butyricum, And The Gut Microbiome Research Behind This Probiotic GLP-1 Supplement…

20 hours ago

MEDVi GLP-1 Investigation: What Consumer Data Shows About Compounded Telehealth Weight Loss Programs

Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility Trends Heading…

20 hours ago